Parkinson's Blog

Discover how a community-led VR trial in the North-East is transforming the treatment landscape for Parkinson’s patients. Explore the innovative approach and promising outcomes of this groundbreak…

As well as a Phase IIb trial of pirepemat, IRLAB is also looking to launch a Phase III trial of its candidate mesdopetam.

Discover the latest research findings on the intricate relationship between aging, Parkinson’s disease, and dopaminergic neurons. Uncover key markers distinguishing healthy and aged cells, sheddin…

Recent research on Parkinson’s disease patients has uncovered a new neurochemical mechanism underlying human decision-making processes based on social context. The study sheds light on the role of…

Enjoy organ performances from members of the American Guild of Organists (St. Louis chapter) and raise money for the American Parkinson’s Disease Association on Monday, March 18, 7:30 p.m. at

Discover how Tanzania, in partnership with the WHO, is revolutionizing access to medication for epilepsy and Parkinson’s disease, offering hope to hundreds of thousands of Tanzanians.

Ita O’Connor, an athlete from Milford is set to feature on the TV series this week

npj Parkinson’s Disease – Synaptic loss and its association with symptom severity in Parkinson’s disease

The UK Court of Appeal has dismissed an appeal brought by Newron Pharmaceuticals concerning an SPC for a drug to treat Parkinson’s disease.